期刊文献+

P16蛋白、P53蛋白、上皮钙粘蛋白(E-cadherin)在原发性肝细胞癌中的表达 被引量:2

Expressions of P16 protein,P53 protein ,E-cadherin in the tissues of primary hepatocellular carcinoma
暂未订购
导出
摘要 目的 了解原发性肝细胞癌及其癌旁组织中P16、P5 3蛋白、上皮钙粘蛋白 (E cadherin)的表达。方法 用免疫组化方法检测 35例人肝细胞癌及其癌旁组织中P16、P5 3蛋白、上皮钙粘蛋白 (E cadherin)表达的改变 ,并结合临床资料进行分析。结果 肝癌和癌旁组织中P16、P5 3蛋白、上皮钙粘蛋白 (E cadherin)阳性率分别为 37.14 %、4 5 .71%、31.4 3%和 10 0 %、11.4 3%、71.4 3%。肝癌的P16蛋白、上皮钙粘蛋白 (E cadherin)表达率明显低于癌旁组织的表达率 ,P <0 .0 5 ,而P5 3蛋白的表达率明显高于癌旁组织的表达率 ,P <0 .0 5 ;P16蛋白、上皮钙粘蛋白 (E cadherin)阳性表达率在无转移的肝癌中分别为 82 .14 %、15 .38%。有转移组分别为 2 8.5 7%、4 0 .91% ;转移与非转移组比较有极显著性差异P <0 .0 1。P16、P5 3蛋白表达与组织学分级有明显关系P <0 .0 5。结论 P16蛋白缺失和 p5 3基因突变 ,与肝细胞癌增殖、分化程度及预后有关。E cadherin的丧失或低表达是肝癌获得高侵袭转移能力的因素之一。 Objective To comprehend the expressions of P16?P53 protein and E cadherin in tumor tissues , peritumor tissues of primary hepatocellular carcinoma Methods P16?P53 protein and E cadherin expressions were studied in 35 cases of HCC by using immunohistochemical method and compared with clinical data.Results P16?P53 protein and E cadherin positive expressions in the tumors and their neighboring regions were 37.14%?45.71%?31.43% and 100%? 11.43%?71.43% respectively?The positive expressions of P16 protein and E cadherin in HCC were significantly lower than those in their neighboring regions( P <0.05).The positive expressions of P53 protein in HCC were significantly higher than those in their neighboring regions( P <0.05).The positive expressions of P16 protein and E cadherin were respectively 82.14%?15.38% without metastasis in the carcinoma and 28.57% ?40.91% with metastasis, with an obvious difference between groups with and without metastasis( P <0.01).Expressions of P16?P53 protein was related to the histological grade.Conclusions P16 protein deletion and P53 gene mutation are closely related to proliferation,differentiation degree and prognosis of HCC.Loss or decreased expression of E cadherin was one of the factors for development of its highly invasive potentials.
出处 《重庆医学》 CAS CSCD 2002年第12期1161-1163,共3页 Chongqing medicine
关键词 肝细胞癌 P16基因 P53基因 上皮钙粘蛋白 免疫组织化学 肿瘤转移 肿瘤浸润 hepatocellular carcinoma P16 gene P53 gene E cadherin Immunohistochemistry neoplasm metastasis neoplasm invasiveness
  • 相关文献

参考文献13

  • 1Serrano M,Hannon GJ,Beach DA.New regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4[J].J Nature,1993,366(6456):704.
  • 2刘素侠,曹英林,张利宁,马春红,王万忠,孙汶生.p16在肝细胞癌组织内变异的研究[J].山东医科大学学报,1999,37(1):13-14. 被引量:2
  • 3黄建钊,沈文律,夏穗生,李波,罗义刚,姜汉英.25例肝癌中p16基因状态的研究[J].癌症,2000,19(1):45-47. 被引量:6
  • 4Yan L,Nichols MA,Jerry WS,et al.Transcriptional repression of the D-type cyclin-dependent kinase inhibitor P16 by the retinoblastoma susceptibility gene product,J pRb[J].Cancer Res,1994,54(23):6078.
  • 5Finlay CA,Hinds PW,LevinevAJ.The P53 proto-oncogenecan acts as a suppressor of transformation[J].Cell,1989,57:1083.
  • 6靳文生,晏才杰,麻晓林,张朝军,陈怡华.胃粘膜癌变过程中细胞增殖活性的研究[J].重庆医学,2001,30(3):203-204. 被引量:4
  • 7Beroud C, Soussi T. P53 gene mutation: software and database[J]. Nucleic Acids Res, 1998,26:200.
  • 8Reed JA,Loganzo FJr,Shea CR,et al.Loss of expression of the P16 cyclin-dependent kinase inhibitor 2 tumor suppressor gene in melanocytic lesions correlates with invasive stage of tumor progression[J].J Cancer Res,1995,55(13):2713.
  • 9Birchmeier W. Cadherin expression in carcinomas:role of the formation of cell junction and the prevention of invasiveness[M].BBA,1994,11.
  • 10Behrens J,Willian G.Epithelial cell acquire invasive properities after the loss of uvomorulin-mediated cell-cell adhesion[J]. J Cell Biol,1989,108:2435.

二级参考文献17

共引文献8

同被引文献33

  • 1刘江,何建方,施柏年,周建方.慢性肝病患者血清基质金属蛋白酶-2和基质金属蛋白酶-2组织抑制因子与肝纤维化指标的关系[J].临床内科杂志,2005,22(8):522-524. 被引量:10
  • 2刘友良,黄平.基质金属蛋白酶-2与肿瘤关系的研究进展[J].现代肿瘤医学,2006,14(1):109-111. 被引量:18
  • 3侯元婕,薛克修.基质金属蛋白酶及其抑制因子与组织纤维化的研究进展[J].新乡医学院学报,2006,23(2):204-206. 被引量:18
  • 4Iijima T, Minami Y, Nakamura N, et al. MMp - 2 activation and stepwise progression of pulmonary adenocarcinoms: analysis of MMP - 2 and MMP - 9 with gelatin zymography [ J ]. Pathol Int, 2004,54 ( 5 ) : 295 -301.
  • 5Yamamoto A, Yano S, Shiraga M,et al. A third -generation matrix metalloproteinase(MMP) inhibitor( ONO -4817 ) combined with docataxel suppression otltmg rnierometastasus of MMP - expression tumor cell in nude mice [ J ]. lnt J Cancer, 2003,103 ( 6 ) : 822 - 828.
  • 6Jodele S, Chantain CF, Blavier L,et al. The contribution of bone marrow cells to the tumor vasculature in neuroblastoma is mastrox metalloproteinase - 9 dependent [ J ]. Cancer Ras,2005,65:3200 - 3208.
  • 7Nagme H, Visse R, Mushy G. Structure and function of matrixmetalloproteinases and TIMPs[ J ]. Cardiovasc Res,2006 ,69 :562 - 573.
  • 8Hilska M, Roberts PJ, Collan YU, et al. Prognostic significanceof matrix metalloproteinases - 1, - 2, - 7 and - 13 and tissue in - hibitors ofmetalloproteinases - 1, - 2, - 3 and - 4 in colorectalcancer [ J ]. lnt J Cancer,2007,121:714 -723.
  • 9Sounni NE, Janssen M, Foidart JM, et al. Membrane type - 1 matrix metallopteinase and TIMP -2 in tumor angiogenesis[ J ]. Matrix Biol, 2003,22:55 -61.
  • 10Rapti M, Knauper V, Murphy G, et al. Characterization of the ABLoop region of TIMP - 2; involvement in Pro - MMP - 2 activation [ J]. J Biol Chem,2006,281 (33) :23386 - 23394.

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部